Evaluating the safety of emicizumab in patients with hemophilia AArielle L. Langer, Louis M. Aledort, Aaron Etra|Expert Opinion on Drug Safety|2018Cited by 18
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysisJoseph A. Pidala, Samantha Jaglowski, Mary ED Flowers et al.|Blood Advances|2024Cited by 16
Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World AnalysisJoseph A. Pidala, Samantha Jaglowski, Mary E.D. Flowers et al.|Transplantation and Cellular Therapy|2024Cited by 0